Cancer Genetics Posts 42 Percent Increase in Q3 Revenues | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer Genetics said after the close of the market on Wednesday that revenues in its third quarter rose 42 percent year over year.

The cancer diagnostics firm reported revenues of $1.7 million for the three months ended Sept. 30, compared to $1.2 million in the year-ago period. Test volume in the recently completed quarter rose 71 percent year over year to 2,920 from 1,704.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.